Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma

Clinical trial NCT03665545 · COMPLETED

Trial details

NCT number: NCT03665545
Sponsor: University Hospital, Geneva
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Glioblastoma, Adult Glioma of Brain Glioblastoma Multiforme of Brain

Start date: 2018-10-25
Primary completion: 2023-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.